JESSICA MEYERS: Open Payments
NPI 1538696604 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 74 payments from 18 companies in 2025. Trend: 2023 $18 · 2024 $536 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $373 |
| AstraZeneca Pharmaceuticals LP | 15 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
| Novo Nordisk Inc | 4 | $77 |
| ACADIA Pharmaceuticals Inc | 2 | $55 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
| HARMONY BIOSCIENCES LLC | 1 | $38 |
| Amgen Inc. | 2 | $35 |
Products named: VRAYLAR, BREZTRI, AIRSUPRA, QULIPTA, CAPLYTA, SPRAVATO, Rybelsus, DAYBUE.
Industry payments across MD — which companies pay providers there.
